ORGANIC
LETTERS
2
007
Vol. 9, No. 23
777-4779
Stereoselective Synthesis of Methyl
-Dihydro-trioxacarcinoside B
4
7
Christian M. K o1 nig, Klaus Harms, and Ulrich Koert*
Fachbereich Chemie, Philipps-UniVersity Marburg, Hans-Meerwein-Strasse,
D-35032 Marburg, Germany
Received August 23, 2007
ABSTRACT
A stereoselective synthesis of 7-dihydro-triocacarcinose B, a branched octose from the quinocyclines, has been achieved. The biocatalytic
resolution of a Baylis Hillman adduct and a subsequent ring-closing metathesis were used to assemble the molecular framework. Subsequent
key steps were a highly stereoselective epoxidation and a regio- and stereoselective opening of the epoxide by allyl alcohol and HClO to
introduce the C(3)-OH group in protected form. The 7-dihydro-triocacarcinose B could be converted into the corresponding 1,7-anhydrosugar.
−
4
Trioxacarcinose B (1) and 7-dihydro-trioxacarcinose B (2)
are structurally related γ-branched octoses found in the
quinocyclines (Figure 1). Quinocycline B and isoquinocy-
As part of a synthetic project toward the quinocyclines,
glycoconjugates of 1 and 2 have to be prepared. Glycocon-
jugates of 1 shall be accessible from glycoconjugates of 2
in a post-glycosylation step by selective oxidation of the C7
hydroxy group. These considerations led us first to develop
an efficient stereoselective synthesis of 7-dihydro-trioxa-
carcinose B (2).
1
cline B contain trioxacarcinose B (1), while quinocycline A
and isoquinocycline A are glycoconjugates of 7-dihydro-
2
trioxacarcinose B (2) and the anthracycline-type aglycone.
Quinocycline B was found to be identical with the recently
3
isolated kosinostatin. Trioxacarcinose B (1) is also part of
A retrosynthetic analysis reveals the regio- and stereose-
lective ring opening of an epoxide as a possible key step
(Figure 1). The properly protected target molecule 3 in its
low-energy chair conformation 4 has the 3,4-oxygen sub-
stituents in trans diaxial positions. This substructure should
be accessible by a regio- and stereoselective attack of a
4
5
trioxacarcin A and gutingimycin.
The antibiotic and cytotoxic activities of natural prod-
ucts containing the octoses 1 or 2 make these rare sugars
interesting to synthetic chemists. So far, a synthetic path
to 7-dihydro-trioxacarcinose B (2) has been reported by
6
7
2
8
Paulsen, and Suami has published a route to trioxacarcinose
B (1). Both made use of a chiral-pool approach starting from
sugar building blocks.
HOR -nucleophile at C3 of the epoxide 6, which leads to
9
the R-epoxide 5 as a key intermediate.
The starting point of the synthesis was a Baylis-Hillman
reaction of methylvinylketone and acetaldehyde followed by
1
0
(
1) (a) Celmer, W. D.; Murai, K.; Rao, K. V.; Tanner, F. W.; Marsh, W.
a biocatalytic resolution to obtain the R-methylene-â-
S. Antiobiot. Ann. 1957-58, 484-492. (b) Tulinsky, A. J. Am. Chem. Soc.
1
964, 86, 5368-5369.
2) Matern, U.; Grisebach, H.; Karl, W.; Achenbach, H. Eur. J. Biochem.
972, 29, 1-4.
3) (a) Furumai, T.; Igarashi, Y.; Higuchi, H.; Saito, N.; Oki, T. J.
(
(6) (a) Paulsen, H.; Sinnwell, V. Chem. Ber. 1978, 111, 869-878. (b)
Paulsen, H.; Sinnwell, V. Chem. Ber. 1978, 111, 879-889.
(7) (a) Suami, T.; Nakamura, K.; Hara, T. Chem. Lett. 1982, 1245-
1248. (b) Suami, T.; Nakamura, K.; Hara, T. Bull. Chem. Soc. Jpn. 1983,
56, 1431-1434.
(8) F u¨ rst, A.; Plattner, P. A. HelV. Chim. Acta 1949, 32, 275-283.
(9) The steroidal R,â-nomenclature is used at this point.
(10) (a) Burgess, K.; Jennings, L. D. J. Org. Chem. 1990, 55, 1138-
1139. (b) Barrett, A. G. M.; Kamimura, A. J. Chem. Soc., Chem. Commun.
1995, 1755.
1
(
Antibiot. 2002, 55, 128-133. (b) Igarashi, Y.; Higuchi, H.; Oki, T.; Furumai,
T. J. Antiobiot. 2002, 55, 134-140; Corrections J. Antiobiotics 2003, 56,
C1.
(
4) Suami, T.; Nakamura, K.; Hara, T. Bull. Chem. Soc. Jpn. 1983, 56,
431-1434.
5) Maskey, R. P.; Sevvana; Uson, M. I.; Helmke, E.; Laatsch, H. Angew.
Chem., Int. Ed. 2004, 43, 1281-1283.
1
(
1
0.1021/ol702078t CCC: $37.00
© 2007 American Chemical Society
Published on Web 10/13/2007